InterAct Therapeutics Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $250K

  • Investors
  • 3

InterAct Therapeutics General Information

Description

Operator of a biotechnology company intended for discovering, developing, and commercializing therapeutics. The company's platform combines engineered viral vectors, target-specific gene delivery, and preclinical translational research capabilities to modify the tumor microenvironment, block metastatic spread, and identify genetic targets, enabling oncology researchers and clinical developers to develop therapeutic candidates that address liver-dominant metastases, optimize preclinical efficacy, and support progression toward clinical development.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 609 Main Street
  • Suite 4200
  • Houston, TX 77002
  • United States
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Corporate Office
  • 609 Main Street
  • Suite 4200
  • Houston, TX 77002
  • United States

InterAct Therapeutics Timeline

2026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

InterAct Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 21-Jul-2026 $250K Completed Generating Revenue
2. Accelerator/Incubator 11-Dec-2025 Completed Generating Revenue
1. University Spin-Out 01-Jan-2025 Completed Startup
To view InterAct Therapeutics’s complete valuation and funding history, request access »

InterAct Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InterAct Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Dais Partners Growth/Expansion
Charles River Incubator Program Accelerator/Incubator
University of Texas Southwestern Medical Center University
To view InterAct Therapeutics’s complete investors history, request access »

InterAct Therapeutics FAQs

  • When was InterAct Therapeutics founded?

    InterAct Therapeutics was founded in 2025.

  • Where is InterAct Therapeutics headquartered?

    InterAct Therapeutics is headquartered in Houston, TX.

  • What is the size of InterAct Therapeutics?

    InterAct Therapeutics has 4 total employees.

  • What industry is InterAct Therapeutics in?

    InterAct Therapeutics’s primary industry is Biotechnology.

  • Is InterAct Therapeutics a private or public company?

    InterAct Therapeutics is a Private company.

  • What is InterAct Therapeutics’s current revenue?

    The current revenue for InterAct Therapeutics is .

  • How much funding has InterAct Therapeutics raised over time?

    InterAct Therapeutics has raised $250K.

  • Who are InterAct Therapeutics’s investors?

    Dais Partners, Charles River Incubator Program, and University of Texas Southwestern Medical Center have invested in InterAct Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process